Crossmark

Clinical features, plasma neurotransmitter levels and plasma neurohormone levels among patients with early-stage Parkinson’s disease with sleep disorders

Crossref DOI link: https://doi.org/10.1186/s12964-025-02153-8

Published Online: 2025-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Cui-Hong

Ren, Ning

Xu, Jing

Chen, Lei
Funding

Funding for this research was provided by:

Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-052B, TJYXZDXK-052B, TJYXZDXK-052B, TJYXZDXK-052B)
License Information

Text and Data Mining valid from 2025-03-18

Version of Record valid from 2025-03-18
More Information

Article History

Received: 27 July 2024

Accepted: 11 March 2025

First Online: 18 March 2025

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki. This study was approved by the ethics committee of Huanhu Hospital, and written informed consent was obtained from all participants.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below